Abstract:

Objective To explore and summarize the therapeutic effect of cytomegalovirus（CMV）infection with valganciclovir prophylaxis after lung transplantation. Methods A retrospective analysis of 11 cases of lung transplantation in patients with clinical data in Henan Provincial People's Hospital from September 2015 to April 2017. We summarized the experience of treatment with valganciclovir prophylaxis after lung transplantation CMV infection. Results 11 cases of patients after lung transplantation were started oral valganciclovir oral 900 mg/d， 3 months of therapy，including 1 cases of postoperative 37 days due to liver and kidney failure，bronchial anastomotic fistula infection 1 cases death loss prevention were lost. The remaining 9 cases had not yet found signs of giant cell virus infection. Effect of CMV infection in lung transplantation. Conclusion Prevention valganciclovir 3 months after the standard is exact and it helps to reduce postoperative complications.